Menopause and stroke and the effects of hormonal therapy

Climacteric

Volumn 10, Issue SUPPL. 2, 2007, Pages 27-31

  Lobo, R A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Estrogen; ISchemic stroke; Menopause; Progestogen

Indexed keywords

ACETYLSALICYLIC ACID; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; RALOXIFENE; TIBOLONE;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; DRUG EFFECT; FEMALE; HAZARD RATIO; HORMONAL THERAPY; HUMAN; MENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; WOMEN'S HEALTH;

AGED; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEX FACTORS; STROKE; UNITED STATES; VENOUS THROMBOSIS; WOMEN'S HEALTH;

EID: 34548846962     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701550903     Document Type: Conference Paper

References (23)

1. Bushnell CD, Hurn P, Colton C, et al. Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-sponsored multidisciplinary working group. Stroke 2006;37:2387-99
2. Glader E-L, Stegmayr B, Norrving B, et al. Sex differences in management and outcome after stroke. A Swedish national perspective. Stroke 2003;34:1970-5
3. Rothwell PM. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-33
4. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673-84
5. Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006;113:2425-34
6. Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 2005;162:404-14
7. Prentice RL, Langer RD, Stefanick ML, et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol 2006;163:589-99
8. Bath PM, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005;330:342
9. Lobo RA, Pickar J. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from four large clinical trials. Presented at 51st ACOG Meeting, New Orleans, October 2003, Poster #7. Obstet Gynecol 2003; Suppl
10. Arana A, Varas C, Gonzalez-Perez A, et al. Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause 2006;13:1-7
11. Li C, Engstrom G, Hedblad B, et al. Risk of stroke and hormone replacement therapy - a prospective cohort study. Maturitas 2006;54:11-18
12. Lokkegaard E, Jovanovic Z, Heitmann BL, et al. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study. Arch Neurol 2003;60:1379-84
13. Heikkinen J, Vaheri R, Timonen U. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: update of safety and quality-oflife findings. J Br Menopause Soc 2006;12:115-25
14. Lemaitre RN, Weiss NS, Smith NL, et al. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Arch Intern Med 2006;166:389-9
15. Suzuki S, Brown CM, Wise PM. Mechanisms of neuroprotection by estrogen. Endocrine 2006;29:209-15
16. Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. Appl Physiol 2006;101:1252-61
17. Alonso de Lecinana M, Egido JA. Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc Dis 2006;Suppl 2:48-53
18. Gibson CL, Gray LJ, Murphy SP, et al. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 2006;26:1103-13
19. Viscoli CM, Brass LM, Kernan WN, et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243-9
20. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304
21. Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-37
22. Cummings SR. LIFT study is discontinued. BMJ 2006;332:667
23. Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41